Engineering Macrophage‐Derived Exosome to Deliver Pirfenidone: A Novel Approach to Combat Silicotic Pulmonary Fibrosis
Advanced Healthcare Materials · 2025-02 · 14 (4)
DOI: 10.1002/adhm.202403227 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 09.10.2024. Verfasst von Zhen Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Medical Research Center for Women and Children Diseases, Key Laboratory of Birth Regulation and Control Technology of National Health Commis…. Hauptthemen laut MEDLINE: Pyridones, Exosomes, Macrophages, Pulmonary Fibrosis. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: Occupational Health Risk Assessment and the Formulation of National Occupational Health Standards, Southwest Center for Occupational and Environmental Health, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Silicosis is a severe lung disease characterized by diffuse pulmonary fibrosis, for which there is currently no effective treatment. Pirfenidone (PFD) shows great antifibrotic potential but is clinically hindered by low bioavailability and gastrointestinal side effects. To address these limitations, this study develops a PFD delivery system (PFD‐Exo) using J774A.1 macrophage‐derived exosomes. Firstly, PFD is loaded via sonication, then PFD‐Exo is characterized using Raman spectral imaging and UV absorption spectroscopy. Finally, in vitro and in vivo silicosis models are established to evaluate its antifibrotic effects. Results show that PFD‐Exo outperforms free PFD in inhibiting TGF‐β1‐induced transdifferentiation of primary lung fibroblasts in vitro. In a mouse model of silicosis, PFD‐Exo is found to be accumulated in the lungs following intratracheal administration and significantly ameliorates pulmonary inflammation and fibrosis while minimizing gastrointestinal side effects. Mechanistic studies reveal that PFD‐Exo modulates the TGF‐β signaling pathway by downregulating SMAD3 and upregulating SMAD7 and NOGGIN. In conclusion, this study provides the first evidence of macrophage‐derived exosomes as an effective PFD delivery system for silicosis treatment and offers a promising strategy for other refractory pulmonary diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Medical Research Center for Women and Children Diseases, Key Laboratory of Birth Regulation and Control Technology of National Health Commission of China, Shandong Provincial Maternal and Child Health Care Hosp…
- Jinan (Preparatory) Key Laboratory of Women's Diseases and Fertility Preservation, Jinan, 250001, China.
- School of Public Health, North China University of Science and Technology, Tangshan, 063000, China.
- School of Public Health, Qingdao University, Qingdao, 266071, China.
- National Institute of Occupational Health and Poison Control, Chinese Center for Disease Control and Prevention, Beijing, 102206, China.
- School of Public Health, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, 250001, China.
ORCID-Profile: Lin Zhang
Förderung
- Occupational Health Risk Assessment and the Formulation of National Occupational Health Standards
- Southwest Center for Occupational and Environmental Health
- China Postdoctoral Science Foundation
- Taishan Scholar Foundation of Shandong Province
- National Natural Science Foundation of China
Zitieren
APA
Chen, Z., Yun, X., Tian, J., Li, F., Zhang, Z., Meng, J., Li, N., Bian, H., Duan, S., & Zhang, L. (2025). Engineering Macrophage‐Derived Exosome to Deliver Pirfenidone: A Novel Approach to Combat Silicotic Pulmonary Fibrosis. Advanced Healthcare Materials, 14(4). https://doi.org/10.1002/adhm.202403227
Vancouver
Chen Z, Yun X, Tian J, Li F, Zhang Z, Meng J, et al. Engineering Macrophage‐Derived Exosome to Deliver Pirfenidone: A Novel Approach to Combat Silicotic Pulmonary Fibrosis. Advanced Healthcare Materials. 2025;14(4). doi:10.1002/adhm.202403227
BibTeX
@article{Chen2025,
author = {Chen, Zhen and Yun, Xiang and Tian, Jiaqi and Li, Fei and Zhang, Zitong and Meng, Jiahua and Li, Ning and Bian, Hongying and Duan, Shuyin and Zhang, Lin},
title = {Engineering Macrophage‐Derived Exosome to Deliver Pirfenidone: A Novel Approach to Combat Silicotic Pulmonary Fibrosis},
journal = {Advanced Healthcare Materials},
year = {2025},
volume = {14},
number = {4},
doi = {10.1002/adhm.202403227}
}
EUVIMED